Livforsakringsbolaget Skandia, Omsesidigt Harmony Biosciences Holdings, Inc. Transaction History
Livforsakringsbolaget Skandia, Omsesidigt
- $2.1 Billion
- Q2 2025
A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 61,700 shares of HRMY stock, worth $2.26 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
61,700
Previous 23,200
165.95%
Holding current value
$2.26 Million
Previous $733,000
165.89%
% of portfolio
0.09%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding HRMY
# of Institutions
280Shares Held
45MCall Options Held
130KPut Options Held
46.5K-
Valor Management LLC Chicago, IL6.62MShares$243 Million91.68% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$214 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.7MShares$172 Million0.0% of portfolio
-
State Street Corp Boston, MA1.58MShares$57.9 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.29MShares$47.3 Million0.03% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.17B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...